chr20-33732015-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001282933.2(ZNF341):c.-7C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000487 in 1,425,798 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0026 ( 3 hom., cov: 31)
Exomes 𝑓: 0.00023 ( 4 hom. )
Consequence
ZNF341
NM_001282933.2 5_prime_UTR
NM_001282933.2 5_prime_UTR
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 1.40
Genes affected
ZNF341 (HGNC:15992): (zinc finger protein 341) Enables DNA binding activity and DNA-binding transcription activator activity. Predicted to be involved in regulation of transcription, DNA-templated. Located in nucleus. Implicated in hyper IgE recurrent infection syndrome 3. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 20-33732015-C-T is Benign according to our data. Variant chr20-33732015-C-T is described in ClinVar as [Benign]. Clinvar id is 3042456.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0026 (395/151780) while in subpopulation AFR AF= 0.00891 (369/41422). AF 95% confidence interval is 0.00816. There are 3 homozygotes in gnomad4. There are 200 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF341 | NM_001282933.2 | c.-7C>T | 5_prime_UTR_variant | 1/15 | ENST00000375200.6 | NP_001269862.1 | ||
LOC124904890 | XR_007067568.1 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF341 | ENST00000375200.6 | c.-7C>T | 5_prime_UTR_variant | 1/15 | 1 | NM_001282933.2 | ENSP00000364346 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00260 AC: 394AN: 151666Hom.: 3 Cov.: 31
GnomAD3 genomes
AF:
AC:
394
AN:
151666
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000370 AC: 23AN: 62180Hom.: 0 AF XY: 0.000283 AC XY: 10AN XY: 35278
GnomAD3 exomes
AF:
AC:
23
AN:
62180
Hom.:
AF XY:
AC XY:
10
AN XY:
35278
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000235 AC: 299AN: 1274018Hom.: 4 Cov.: 30 AF XY: 0.000227 AC XY: 142AN XY: 626414
GnomAD4 exome
AF:
AC:
299
AN:
1274018
Hom.:
Cov.:
30
AF XY:
AC XY:
142
AN XY:
626414
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00260 AC: 395AN: 151780Hom.: 3 Cov.: 31 AF XY: 0.00270 AC XY: 200AN XY: 74184
GnomAD4 genome
AF:
AC:
395
AN:
151780
Hom.:
Cov.:
31
AF XY:
AC XY:
200
AN XY:
74184
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ZNF341-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 04, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at